Elsevier,
Annals of Hepatology, Volume 28, 1 January 2023
This article aligns with the SDG goal 3 of Good health and wellbeing and SDG 10 Reduced inequalities by evidencing that the magnitude of hepatitis delta virus (HDV) infection increases with the severity of liver disease among chronic hepatitis B patients in Ethiopia.
Elsevier, Alzheimer's Disease and Advanced Drug Delivery Strategies, Volume , 1 January 2023
Alzheimer's disease (AD) is a severe global public health issue because it is an irreversible neurodegeneration of the brain that impairs personality, cognition, memory, and other functions before it ultimately results in death from total brain failure.
Elsevier, Side Effects of Drugs Annual, Volume 45, January 2023
Medications used in the treatment of Alzheimer's disease include the acetylcholinesterase inhibitors (AChEIs, i.e., donepezil, rivastigmine, and galantamine), the N-methyl-D-aspartate receptor (NDMAR) antagonist, memantine, and the anti-amyloid beta monoclonal antibody, aducanumab.
Elsevier, Diet and Nutrition in Neurological Disorders, Volume , 1 January 2023
This chapter discusses any plausible correlation between malnutrition and the onset of Alzheimer's disease. An overview of Alzheimer's pathophysiology is included to offer an understanding of the various underlying causes leading to its manifestation.
Elsevier,
One Earth, Volume 6, 20 January 2023
Marine aquaculture is predicted to serve an important role in alleviating pressure on fisheries and land-based food production, but aquaculture will not be sustainable without continued innovations in the aquaculture sector. Strong governance and economic conditions play a small but highly significant role in the development of marine aquaculture speices
Elsevier,
Handbook of Lifespan Cognitive Behavioral Therapy: Childhood, Adolescence, Pregnancy, Adulthood, and Aging, Volume , 1 January 2023
This content aligns with Goal 3: Good Health and Wellbeing and Goal 10: Reduced Inequalities by discussing the application of cognitive behavior therapy, an evidence-based psychological approach in adolescents suffering from Asperger syndrome with comorbid depressive disorder.
